1. 409: BARICITINIB VERSUS TOCILIZUMAB FOR THE TREATMENT OF MODERATE TO SEVERE COVID-19. (15th December 2022) Authors: Lewis-Wolfson, Temeka; Joyner, Kayla; Reid, Nancy Journal: Critical care medicine Issue: Volume 51(2023)Supplement 1 Page Start: 191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗